Table 2 Individuals that were eligible (n, % total) and those who received services (n, % of those eligible for each service) in intervention and control groups
Service | Eligibility criteria in patients registered at the GP practice who received the intervention between 1st July 2021 and 30th April 2022a | N eligible individuals (% of total) | N eligible individuals (% of total) | p-value (Chi-squared test) | N individuals who received the service (% of total) | N individuals who received the service (% of total) | p-value (Chi-squared test) |
|---|---|---|---|---|---|---|---|
| Â | Â | Intervention | Control | Â | Intervention | Control | Â |
Immunisations | |||||||
 COVID-19 (1st dose) |  > 12 yrs. as of 31st Jan 2021. We assumed all individuals eligible for the vaccine given changes in eligibility criteria throughout the study period | 608 (100%) | 1643 (100%) | - | 48 (8%) | 94 (6%) | 0.06 |
 COVID-19 (2nd dose) | 608 (100%) | 1643 (100%) | - | 97 (16%) | 205 (12%) | 0.03* | |
 COVID-19 (booster) | 608 (100%) | 1643 (100%) | - | 213 (35%) | 376 (23%) |  < 0.01* | |
 Shingles | 70–79 years of age (born between 1st Jul 1942 and 31st Jan 1952) | 30 (5%) | 68 (4%) | - | 2 (7%) | 4 (6%) | 0.88 |
 DTaP/IPV/Hib/HepB | 2, 3 and 4 months (born between 1st Mar 2021 and 31st Jan 2022) only pts who received 3rd dose of vaccine included | 1 (0%) | 7 (0%) | 0.41 | 0 (0%) | 0 (0%) | - |
 DTaP/IPV | 3 years and 4 months to 5 years (born between 1st Jul 2016 and 1st Oct 2018) | 8 (1%) | 23 (1%) | 0.35 | 1 (13%) | 4 (17%) | 0.75 |
 Hib/MenC | 12 months to 3 years and 4 months (born between 1st Mar 2018 and 31st Jan 2021) | 7 (1%) | 28 (2%) | 0.88 | 0 (0%) | 3 (11%) | 0.37 |
 HPV | 12–13 yrs. (born between 1st Jul 2008 and 31st Jan 2010) | 12 (2%) | 20 (1%) | 0.35 | 1 (8%) | 0 (0%) | 0.19 |
 Influenza | 2–16 OR 65 + (born between 1st September 2005 and 31st March 2020 OR before 31st March 1957) or any age if in an at-risk group | 173 (28%) | 417 (25%) | 0.18 | 49 (28%) | 62 (15%) |  < 0.01* |
 MenB (3rd dose) | 12 months to 3 yrs. and 4 mns (born between 1st March 2018 and 31st January 2021) | 7 (1%) | 28 (2%) | 0.14 | 0 (0%) | 3 (11%) | 0.37 |
 MMR (1st dose) | 1–5 yrs. (born between 30th Jun 2016 and 31st Jan 2021 who received the vaccines between 1st Jul 2021—30th Apr 2022 | 13 (2%) | 46 (3%) | 0.35 | 0 (0%) | 3 (7%) | 0.34 |
 MMR (2nd dose) | 13 (2%) | 46 (3%) | 0.16 | 0 (0%) | 0 (0%) | - | |
 PCV (1st dose) | 3 months (born between 1st Apr 2021 and 31st Jan 2022) | 1 (0%) | 7 (0%) | 0.38 | 1 (100%) | 5 (71%) | 0.54 |
 PCV (2nd dose) | 12 months (born between 30th June 2020 and 31st January 2021) | 1 (0%) | 5 (0%) | 0.35 | 0 (0%) | 3 (60%) | 0.27 |
 PPV |  > 65 yrs. (born before 30th April 1957) | 97 (16%) | 247 (15%) | 0.57 | 2 (2%) | 1 (0%) | 0.14 |
 Rotavirus | 2 and 3 months (born between 1st Apr 2021 and 31st Jan 2022) only pts who received 2nd dose included | 1 (0%) | 7 (0%) | 0.59 | 1 (100%) | 5 (71%) | 0.54 |
Screenings and NHS Health Check | |||||||
 Bowel cancer | 60–74 yrs., every 2 yrs., Last screening before July 2020. (born between 1st July 1947 and 31st January 1962) | 39 (22%) | 79 (16%) | 0.11 | 12 (31%) | 26 (33%) | 0.81 |
 Breast cancer | Women 50–71, every 3 years Last screening before July 2019 (born between 1st Jul 1950 and 31st Jan 1972 | 32 (18%) | 65 (14%) | 0.15 | 1 (3%) | 0 (0%) | 0.15 |
 Cervical cancer | Women 25–49 years, every 3 years Last screening before July 2019. (born between 1st Jul 1972 and 31st Jan 1997) | 81 (46%) | 274 (57%) | 0.01* | 11 (14%) | 25 (9%) | 0.24 |
 Cervical cancer | Women 50–64 years, every 5 years Last screening before July 2017. (born between 1st July 1957 and 31st January 1972) | 43 (24%) | 78 (16%) | 0.02* | 4 (9%) | 8 (10%) | 0.87 |
 NHS Health Check | 40–74 years, every 5 yearsb Last NHS Health Check before July 2017. (born between 1st July 1947 and 31st January 1982) | 51 (29%) | 105 (22%) | 0.07 | 18 (35%) | 13 (12%) |  < 0.01* |